Ipamorelin Reconstitution and Dosing Math: mg, mL, IU, and Units Explained

What Is Ipamorelin and Why Does the Math Matter?

Ipamorelin (CAS 170851-70-4) is a selective growth-hormone secretagogue that binds the ghrelin receptor (GHSR-1a) without meaningfully raising cortisol, prolactin, or ACTH at therapeutic doses. A 2004 study by Raun et al. Published in European Journal of Endocrinology showed that ipamorelin produced dose-dependent GH release in rats with high receptor selectivity compared with other GHRPs [1]. Because the peptide is dispensed as a dry powder, every patient must perform a small arithmetic calculation to convert vial contents into an injectable concentration.

Why Precision Matters for Peptide Dosing

Errors in reconstitution math directly produce errors in administered dose. Doubling the diluent volume halves the concentration, so the same syringe fill delivers half the intended micrograms. Halving the diluent doubles the concentration, risking unintended overdose. Compounding pharmacies typically provide a certificate of analysis confirming peptide purity of ≥ 98% by HPLC, and USP <797> guidelines govern sterile preparation standards for compounded sterile preparations [2].

The Unit Confusion Problem

The word "units" on an insulin syringe does not refer to International Units in the endocrine sense. One unit on a U-100 syringe equals 0.01 mL. That single fact resolves nearly every dosing-math question.

Supplies You Need Before You Start

Gather all materials before opening any vial. Cross-contamination and particulate introduction are the two most common errors in home peptide preparation.

Required Items

• Lyophilized ipamorelin vial (confirm mg amount on label)
• Bacteriostatic water for injection, USP (multiple manufacturers; confirm 0.9% benzyl alcohol content)
• U-100 insulin syringes, 0.5 mL or 1 mL barrel, 28 to 31 gauge needle
• Alcohol prep pads (70% isopropyl)
• A clean, flat surface

Bacteriostatic water is the correct diluent for multi-dose peptide vials. The benzyl alcohol preservative inhibits microbial growth over the 28-to-30-day use period after reconstitution [3]. Plain sterile water for injection lacks this preservative and is appropriate only for single-use preparations. The FDA's guidance on compounded sterile preparations reinforces that multi-dose containers require an antimicrobial agent unless the formulation itself provides adequate protection [4].

What to Avoid

Do not use normal saline (0.9% sodium chloride) as a substitute. Saline is isotonic but not bacteriostatic, and chloride ions may interact with the peptide over time. Sodium chloride injection is formulated for intravenous fluids, not peptide reconstitution in multi-dose vials [5].

Step-by-Step Reconstitution Technique

Proper aseptic technique reduces the risk of vial contamination. USP <797> defines the minimum requirements for compounded sterile preparations, including hand hygiene and surface disinfection [2].

Step 1: Wash Hands and Prepare the Surface

Wash hands with soap and water for at least 20 seconds. Wipe the work surface with a 70% isopropyl alcohol pad and allow it to dry completely. Do not fan or blow on the surface to speed drying.

Step 2: Disinfect Both Vial Stoppers

Wipe the rubber stopper of the ipamorelin vial and the stopper of the bacteriostatic water vial with separate alcohol pads. Allow each to air-dry for 10 seconds. Never touch the stopper after cleaning.

Step 3: Draw Bacteriostatic Water

Using a fresh insulin syringe or a separate 3 mL syringe, draw the desired volume of bacteriostatic water (see concentration table in the next section). Insert the needle at a 45-to-90-degree angle through the cleaned stopper of the bacteriostatic water vial.

Step 4: Inject Water Into the Peptide Vial

Direct the stream of bacteriostatic water down the inside wall of the ipamorelin vial. Do not aim the stream directly at the lyophilized cake. Forceful direct injection can shear peptide bonds and degrade the compound. This slow-wall technique is consistent with peptide stability best practices described in pharmaceutical reconstitution literature [6].

Step 5: Swirl, Do Not Shake

Gently roll the vial between your palms for 15 to 20 seconds. The lyophilized powder should dissolve into a clear, colorless solution. Shaking introduces air bubbles and may cause peptide aggregation. If the solution appears cloudy or shows visible particles after gentle mixing, discard the vial.

Step 6: Label and Refrigerate

Write the reconstitution date on the vial. Store at 2 to 8 °C (standard household refrigerator). Use within 28 to 30 days. Do not freeze a reconstituted peptide vial; freezing disrupts the aqueous solution and may precipitate aggregation [7].

Reconstitution Math: Choosing Your Diluent Volume

The concentration of your reconstituted solution depends entirely on how much bacteriostatic water you add to the vial. The formula is simple:

Concentration (mcg/mL) = Vial content (mcg) ÷ Volume of diluent added (mL)

Because 1 mg = 1,000 mcg, a 5 mg vial contains 5,000 mcg of ipamorelin.

Concentration Table for Common Vial Sizes

| Vial Size | Bacteriostatic Water Added | Resulting Concentration | |-----------|---------------------------|------------------------| | 2 mg (2,000 mcg) | 1 mL | 2,000 mcg/mL | | 2 mg (2,000 mcg) | 2 mL | 1,000 mcg/mL | | 5 mg (5,000 mcg) | 1 mL | 5,000 mcg/mL | | 5 mg (5,000 mcg) | 2 mL | 2,500 mcg/mL | | 5 mg (5,000 mcg) | 4 mL | 1,250 mcg/mL | | 10 mg (10,000 mcg) | 2 mL | 5,000 mcg/mL | | 10 mg (10,000 mcg) | 4 mL | 2,500 mcg/mL |

Most clinicians recommend adding 2 mL to a 5 mg vial to yield 2,500 mcg/mL. This concentration places a 200 mcg dose at 8 units and a 300 mcg dose at 12 units on a U-100 syringe, making the math easy to verify without a calculator.

The Insulin Syringe Explained: Units vs. ML vs. Mcg

This is the section that resolves the greatest source of patient confusion. Understanding these three scales simultaneously is the core skill.

U-100 Syringe Scale

A U-100 insulin syringe holds 1 mL of fluid divided into 100 equal units. Each unit therefore equals exactly 0.01 mL. The "U-100" label refers to insulin concentration (100 units of insulin per mL) and has no bearing on peptide concentration. When you draw peptides, ignore the insulin insulin-unit labeling and treat each mark as 0.01 mL [8].

The Core Formula

Units to draw = (Desired dose in mcg ÷ Concentration in mcg/mL) × 100

The multiplication by 100 converts mL into the syringe's 0.01-mL unit marks.

Worked Examples at 2,500 mcg/mL

Example 1: 200 mcg dose

• Volume needed: 200 ÷ 2,500 = 0.08 mL
• Units to draw: 0.08 × 100 = 8 units

Example 2: 250 mcg dose

• Volume needed: 250 ÷ 2,500 = 0.10 mL
• Units to draw: 0.10 × 100 = 10 units

Example 3: 300 mcg dose

• Volume needed: 300 ÷ 2,500 = 0.12 mL
• Units to draw: 0.12 × 100 = 12 units

Worked Examples at 1,000 mcg/mL

Example 4: 200 mcg dose

• Volume needed: 200 ÷ 1,000 = 0.20 mL
• Units to draw: 0.20 × 100 = 20 units

Example 5: 300 mcg dose

• Volume needed: 300 ÷ 1,000 = 0.30 mL
• Units to draw: 0.30 × 100 = 30 units

Clinical Dosing Guidance for Ipamorelin

Ipamorelin dosing in clinical practice typically falls into three tiers based on therapeutic goal. These ranges reflect patterns in published pharmacodynamic data and compounding pharmacy protocols rather than an FDA-approved label, because ipamorelin is not currently an approved finished drug product in the United States [9].

Tier 1: GH Pulse Optimization (General Wellness and Body Composition)

The most commonly prescribed range is 200 to 300 mcg per injection, administered once or twice daily. Timing injections to coincide with the body's natural GH pulses (early morning on an empty stomach, or 30 to 60 minutes before bed) may augment the secretagogue effect. A 1999 clinical pharmacology study by Chapman et al. In Journal of Clinical Endocrinology and Metabolism demonstrated that GH-releasing peptides administered at night produced GH pulses consistent with physiological rhythms [10].

Tier 2: Recovery and Anti-Aging Protocols

Doses of 200 to 300 mcg administered three times daily are used in some compounding-pharmacy protocols targeting soft-tissue recovery. At this frequency, a 5 mg vial reconstituted to 2,500 mcg/mL provides approximately 8.3 days of supply per injection cycle at 300 mcg per dose. Patients should factor vial expiration (28 days post-reconstitution) into prescription quantity [11].

Tier 3: Research-Context High-Dose Protocols

Some investigational contexts have used doses up to 500 mcg per injection. Above 300 mcg, the marginal increase in GH release tends to plateau based on GHSR-1a receptor saturation kinetics described in GHRP pharmacology literature [12]. Prescribing clinicians should weigh receptor saturation data against individual patient IGF-1 levels, which should be monitored every 3 to 6 months during therapy.

Ipamorelin Versus Other GHRPs: Selectivity Profile

Ipamorelin's primary distinguishing feature is its low impact on cortisol and ACTH compared with GHRP-6 and GHRP-2. A study by Bowers et al. In Endocrinology characterized the differential ACTH responses across GHRP family members, noting ipamorelin's narrow selectivity for GH release [13]. This profile makes it a preferred secretagogue for patients sensitive to cortisol elevation. For clinical monitoring of GH axis activity, the Endocrine Society's 2019 clinical practice guideline on growth hormone deficiency in adults recommends serum IGF-1 as the primary biochemical marker [14].

Stability, Storage, and Shelf Life

Peptide stability after reconstitution depends on temperature, light exposure, and the presence of a preservative.

Lyophilized (Unreconstituted) Vials

Lyophilized ipamorelin is stable at room temperature for short periods during shipping but should be stored at 2 to 8 °C for long-term storage of up to 24 months from manufacture. Some sources indicate stability at room temperature for 4 to 8 weeks if unopened; however, refrigeration is the conservative and recommended practice [7].

Reconstituted Solution Stability

After adding bacteriostatic water, the 28-to-30-day refrigerated use period is the standard applied by USP <797> for Category 1 compounded sterile preparations [2]. Benzyl alcohol at 0.9% provides antimicrobial protection throughout this window. Peptide degradation in aqueous solution proceeds via hydrolysis, oxidation, and aggregation pathways. Low temperature slows all three. A review of peptide formulation stability published in the Journal of Pharmaceutical Sciences confirmed that refrigerated storage at 4 °C substantially extends solution-phase peptide half-life compared with room-temperature storage [15].

Visual Inspection Before Each Use

Before drawing each dose, hold the vial up to light. A properly stored reconstituted peptide solution should be clear and colorless. Discard the vial if you observe cloudiness, color change, or visible particles. These findings indicate either microbial contamination or peptide precipitation [6].

Injection Technique: Subcutaneous Administration

Ipamorelin is administered subcutaneously, not intramuscularly or intravenously.

Site Selection

Common sites include the abdomen (at least 2 inches from the navel), outer thighs, and flanks. Rotate injection sites with each dose to minimize lipodystrophy, the localized fat-tissue change that can occur from repeated injections at the same site. The American Diabetes Association's standards on insulin injection technique provide the foundational framework for subcutaneous injection site rotation that applies equally to peptide injections [16].

Injection Steps

1. Clean the chosen skin site with an alcohol swab and allow to dry.
2. Pinch a fold of skin between thumb and forefinger.
3. Insert the needle at 45 degrees (thin individuals) or 90 degrees (more subcutaneous tissue).
4. Release the skin fold and depress the plunger slowly and steadily.
5. Withdraw the needle and apply gentle pressure with a clean pad. Do not rub.

Needle Gauge Selection

A 28- to 31-gauge needle on a 0.5 mL or 1 mL insulin syringe is appropriate. Finer gauges (30 or 31) reduce injection discomfort at the cost of slightly slower flow. At peptide injection volumes of 0.08 to 0.30 mL, flow time difference between gauges is negligible in practice [17].

Common Dosing Errors and How to Prevent Them

Error 1: Confusing mg and mcg

A 5 mg vial holds 5,000 mcg. Prescriptions and vial labels may use either unit. Always convert to mcg before doing any math. One milligram equals one thousand micrograms.

Error 2: Wrong Diluent Volume

Adding 1 mL instead of 2 mL to a 5 mg vial doubles the concentration. At doubled concentration, drawing the habitual number of syringe units delivers twice the intended dose. Write the diluent volume on the vial label immediately after reconstitution.

Error 3: Reading the Syringe Incorrectly

On a 1 mL U-100 syringe, each major line represents 10 units (0.10 mL); each minor line represents 2 units (0.02 mL) on most barrels, or 1 unit (0.01 mL) on 0.5 mL low-dose barrels. Confirm your syringe's graduation before first use [8].

Error 4: Skipping Visual Inspection

A vial that has been left unrefrigerated for more than 24 hours, or that shows any turbidity, should be discarded. The cost of replacing a vial is far lower than the risk of injecting a degraded or contaminated solution.

Quick Reference Dosing Table

The table below covers the most common clinical scenario: a 5 mg vial reconstituted with 2 mL of bacteriostatic water for a concentration of 2,500 mcg/mL.

| Desired Dose | Volume (mL) | Syringe Units (U-100) | |-------------|------------|----------------------| | 100 mcg | 0.04 mL | 4 units | | 150 mcg | 0.06 mL | 6 units | | 200 mcg | 0.08 mL | 8 units | | 250 mcg | 0.10 mL | 10 units | | 300 mcg | 0.12 mL | 12 units | | 400 mcg | 0.16 mL | 16 units | | 500 mcg | 0.20 mL | 20 units |